Eribulin Mesylate Injection

Product description

Eribulin Mesylate Injection is used to treat certain patients with breast cancer and liposarcoma.

Strength: 1mg/2ml

This product is still in R & D stage.
Read more


Categories Finished Dosage FormsInjectables; Finished Dosage Forms
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (78)

Products from other suppliers

Eribulin Mesylate Injection

Contact information




View all contact information